Skip to content
Malawi Clinical GuidelinesGuidelinesGet app

6.3

Presumed severe HIV disease in infants (PSHD)

Clinical HIV Guidelines, 5th Edition, 2022. Chapter 6, Diagnosing HIV infection and exposure.

Clinical description

  • Infants infected with HIV develop life-threatening HIV-related disease much more quickly than

older children and adults.

  • Conduct point of care DNA-PCR testing on site for timely clinical decision making, if available.
  • However, it may take too long to confirm HIV infection in a sick infant using DNA-PCR.
  • Under the age of 12 months, a positive HIV rapid antibody test does not confirm HIV infection

because maternal antibodies pass through the placenta and remain in the baby’s blood for several months.

  • However, a positive rapid antibody test in an infant with the following clinical signs makes severe

HIV disease (AIDS) very likely:

Table 4: Definition of presumed severe HIV disease (PSHD)

Table 4 — Definition of presumed severe HIV disease (PSHD)
Table 4 — Definition of presumed severe HIV disease (PSHD). Open the image to zoom.

Infant with positive rapid antibody test PLUS:

Combination of 2: OR At least 1:

  • Oral thrush • Severe unexplained wasting / malnutrition not

responding to treatment

  • Severe pneumonia
  • Pneumocystis pneumonia
  • Severe sepsis
  • Candidiasis of oesophagus, trachea, bronchi or lungs
  • Cryptococcal meningitis
  • Cerebral Toxoplasmosis (from age 1 month)
  • Start ART as quickly as possible for infants with PSHD – do not wait for a DNA-PCR result.
  • Collect a DBS sample for DNA-PCR confirmatory testing on the day of starting ART (see section 16.3

on page 78).

Spotted an error? Report it by

Need this without data?

The app holds every guideline on your device, with calculators, bookmarks and notes.